Muscular Dystrophy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with Myotonic Dystrophy Type 1 (DM1) or Type 2 (DM2), either through genetic testing or based on symptoms — even if you haven't had genetic testing done.
- You are a healthy person with no known muscular dystrophy (for comparison purposes in the study).
- You are able to give your consent (or, for younger participants, give your agreement/assent) to take part in the study.
- For a single sample collection (blood, urine, or similar): you are male or female, aged 5 years or older, with or without DM.
- For repeated sample collections over time: you are male or female, aged 14 or older, and have DM1.
- For sample collection that includes a muscle biopsy: you are male or female, aged between 18 and 65 years.
Who may not be able to join:
- You have a history of a weakened immune system, a blood-clotting disorder, liver disease, kidney disease, HIV, or Hepatitis B or C.
- You have taken blood-thinning or anti-clotting medications within the past 7 to 60 days before a blood draw or biopsy (confirm with trial site for exact timeframes).
- You are currently using or dependent on drugs or alcohol in a way that could affect your recovery after a biopsy, in the opinion of the doctor performing the procedure.
- You are pregnant, planning to become pregnant before a biopsy, or have a positive pregnancy test.
- You are unwilling or unable to give written consent (or assent) to take part in the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Thurman M. Wheeler, MD, Massachusetts General Hospital
Phone: 617-726-7506
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Extracellular RNA splice variants in biofluids
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.